Müller-Ehmsen J, Frank K, Brixius K, Schwinger R H
Klinik III für Innere Medizin, Universität zu Köln, Germany.
Br J Clin Pharmacol. 1997 Apr;43(4):399-405. doi: 10.1046/j.1365-2125.1997.00581.x.
The aim of the present study was to investigate whether agents which enhance force of contraction via increasing intracellular Na+, i.e. cAMP-independently, remain effective in failing human myocardium.
Cumulative concentration-response curves with (+/-)BDF 9148 (0.01-10 mumol l-1), a Na(+)-channel activator, and ouabain (0.01-0.1 mumol l-1), a Na+/K(+)-ATPase inhibitor, were performed on electrically driven left ventricular human papillary muscle strips (1 Hz, 37 degrees C; dilative cardiomyopathy, NYHA IV, heart transplantation, n = 16; nonfailing, donor hearts, n = 5). The beta-adrenoceptor agonist isoprenaline (0.001-1 mumol l-1) and Ca2+ (1.8-15 mmol l-1) were studied for control. In addition, Ca2+ response curves were obtained on skinned fibre preparations from left ventricular myocardium (NYHA IV, n = 7) in the presence of BDF 9148 (1 mumol l-1) or a high Na+ concentration (50 mmol l-1) to investigate a possible direct or indirect interaction of (+/-)BDF 9148 with the myofilaments.
While isoprenaline was significantly less effective in increasing force of contraction in failing human myocardium than in nonfailing myocardium (P < 0.01), in NYHA IV, (+/-)BDF 9148 and ouabain were as effective as in nonfailing human tissue. In failing and nonfailing myocardium, (+/-)BDF 9148 and ouabain exerted positive inotropic effects similar to those of Ca2+. However, the potency for (+/-)BDF 9148 to increase force of contraction was higher in NYHA IV than in nonfailing human myocardium (P < 0.05). Neither (+/-)BDF 9148 (1 mumol l-1) nor an increased concentration of Na+ (50 mmol l-1) altered the Ca2+ sensitivity or maximal developed tension of the contractile apparatus in experiments on chemically skinned left ventricular fibres.
The enhanced sensitivity of the failing human myocardium towards Na(+)-channel modulation is not due to a direct or indirect interaction of (+/-)BDF 9148 with cardiac myofilaments but may be due to an altered Na(+)-homeostasis in human heart failure.
本研究旨在探究通过增加细胞内钠离子浓度(即不依赖环磷酸腺苷)来增强收缩力的药物在衰竭的人类心肌中是否仍然有效。
对电驱动的人类左心室乳头肌条(1赫兹,37摄氏度;扩张型心肌病,纽约心脏协会心功能IV级,心脏移植患者,n = 16;非衰竭供体心脏,n = 5)进行(±)BDF 9148(0.01 - 10微摩尔/升)(一种钠离子通道激活剂)和哇巴因(0.01 - 0.1微摩尔/升)(一种钠钾ATP酶抑制剂)的累积浓度 - 反应曲线实验。以β - 肾上腺素能受体激动剂异丙肾上腺素(0.001 - 1微摩尔/升)和钙离子(1.8 - 15毫摩尔/升)作为对照进行研究。此外,在存在BDF 9148(1微摩尔/升)或高钠离子浓度(50毫摩尔/升)的情况下,对左心室心肌的脱细胞纤维制剂(纽约心脏协会心功能IV级,n = 7)进行钙离子反应曲线实验,以研究(±)BDF 9148与肌丝之间可能存在的直接或间接相互作用。
虽然异丙肾上腺素在增加衰竭人类心肌收缩力方面的效果明显低于非衰竭心肌(P < = 0.01),但在纽约心脏协会心功能IV级患者中,(±)BDF 9148和哇巴因的效果与非衰竭人类组织相同。在衰竭和非衰竭心肌中,(±)BDF 9148和哇巴因产生的正性肌力作用与钙离子相似。然而,在纽约心脏协会心功能IV级患者中,(±)BDF 9148增加收缩力的效力高于非衰竭人类心肌(P < 0.05)。在化学脱细胞的左心室纤维实验中,(±)BDF 9148(1微摩尔/升)和增加的钠离子浓度(50毫摩尔/升)均未改变收缩装置的钙离子敏感性或最大张力。
衰竭的人类心肌对钠离子通道调节的敏感性增强并非由于(±)BDF 9148与心肌肌丝之间的直接或间接相互作用,而可能是由于人类心力衰竭时钠稳态的改变。